geriatric assessment and interventions - geriatric oncology · geriatric assessment and...

66
Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital Norway

Upload: others

Post on 17-Jun-2020

39 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Geriatric Assessment and

Interventions

Siri Rostoft, MD, PhD

Department of Geriatric Medicine

Oslo University Hospital

Norway

Page 2: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Disclosure

No conflicts of interest to declare

Page 3: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Mrs A, aged 94

• Admitted to the acute geriatric ward

because of fatigue and dizziness

• Work up revealed severe iron-deficiency

anemia (she was bleeding)

• Colonoscopy revealed right sided large

colon cancer, narrow passage

• Surgery?

Page 4: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Decrease in capacity - heterogeneity

Muravchik, Anesthesia 5th ed, 2000

Page 5: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Geriatric assessment (GA)1

- Functional status

- Comorbidity

- Polypharmacy

- Cognitive function/

dementia

- Nutritional status

- Depression

- Social support

Remaining life expectancy

Detection of unidentified problems

Optimization before treatment

Prediction of adverse outcomes

Treatment planning

Baseline information

FRAILTY

1Wildiers et al, JCO, 2014

Page 6: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital
Page 7: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Studies included in review

• CGA and ability to detect health problems: n=29

• CGA and prediction of outcomes: n=17

• CGA and tailored interventions: n=3

Page 8: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Results

• All CGA types identified

- large numbers of geriatric problems

- multiple comorbidities likely to interfere with

cancer treatment and to compete with cancer as a

cause of death

• Some CGA domains may influence treatment decisions

– functional status and nutritional status may have the strongest effect

Page 9: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Results cont.

• Each CGA domain was associated with chemotoxicity and survival in at least one study

• The domains most often predicting mortality and chemotoxicity:

– functional impairment

– malnutrition

– comorbidities

Page 10: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital
Page 11: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Methods and results

• 10 studies included in the review

• Change in oncologic treatment:

– the initial treatment plan modified in 39% of patients

after geriatric evaluation

– two thirds resulted in less intensive treatment

• Implementation of non-oncologic interventions

– interventions were suggested for more than 70% of patients

– most frequently social interventions and pharmacological interventions

Page 12: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Conclusion

• A geriatric evaluation has significant impact on

oncologic and non-oncologic treatment

decisions in older cancer patients

Page 13: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Journal of Surgical Research 193 (2015) 265-272

Page 14: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Results

• Elective surgery only

• 10 publications from 6 studies

• GA domains predicting overall and major complications

– dependency in ADLs and IADLs (functional status)

– higher ASA score

– decreased mini-mental state examination score

– worse geriatric depression score

– worse frailty scores

– fatigue

Journal of Surgical Research 193 (2015) 265-272

Page 15: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Results cont.

• Age was not an independent predictor of morbidity

in any studies

• No GA domains predicted postoperative mortality

(low mortality rates in elective surgery)

• Frailty predicted readmissions

• Functional status and frailty predicted discharge to

a nursing home

Journal of Surgical Research 193 (2015) 265-272

Page 16: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Categorization

Geriatric assessment

Geriatric assessment

FitFit IntermediateIntermediate FrailFrail

Page 17: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Geriatric assessment

• Overall assessment

• Multidisciplinary

• Areas where older patients often have

problems

• CGA – assessment with interventions

• Implementing GA in older hospitalized adults

increases likelihood of being alive and living in

their own home1

1Ellis Cochrane Rev 2011

Page 18: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

GA in oncology

• Delphi study1:

• All cancer patients > 70 years

• Younger with age-related issues

• Most important domains:

– Functional status

– Comorbidities

– Cognitive function

1O´Donovan et al 2015

Page 19: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Mrs A – Geriatric Assessment

• Functional status: Dependence in IADL. Needed help shopping. Problems walking, uses a cane. TUG > 20 sec

• Comorbidity: Heart failure – but is the diganosis correct? She can walk one flight of stairs without being out of breath. Stroke in 2008, no apparent sequela. Reduced vision and reduced hearing.

• Polypharmacy: beta blocker and diuretics

Page 20: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

• Nutritional status: No appetite last month (due to tumour), weight loss, at risk of malnutrition

• Cognitive function: MMSE 27/30, she appeared adequate in conversation, she could discuss treatment options

• Emotional status: No symptoms of depression

Page 21: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Recommendation

• She had some frailty indicators, risk of post-

operative complications high

• Complications from tumour at present

(anemia, weight loss)

• Risk in emergency surgery much higher than

elective surgery

• Operated electively, had some complications,

survived, discharged home

Page 22: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

A FEW WORDS ABOUT FUNCTIONAL

STATUS

Page 23: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Case – man with rectal cancer

• 69 years old, home dwelling

• Locally advanced rectal cancer

• Admitted for preoperative chemoradiotherapyaccording to guidelines

• After a week non-cooperative, pulled out i.v.lines, completely bed-ridden, aggressive

• What do we call this? Any risk factors?

Page 24: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

What about functional status?

• The majority of people aged 80 years have a

good functional status and live independent

lives (75% in a Swedish study) despite having

chronic diseases

• Frequently large changes in health status

around ages 80-85

Page 25: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

“She Was Probably Able to Ambulate,

but I’m Not Sure”

• Failure to assess functional status in hospitalized patients is the norm

• Basic: ADL-function, mobility, and cognition

• 1/3 of patients 70+ encounter hospitalization-associated disability (even when acute illness is effectively treated)

Covinsky JAMA 2011

Page 26: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

How to measure functional status

ADL = activities of daily living

- survive (eat, go to the toilet)

IADL = instrumental ADL

- live independently (manage money, shop,

medication use)

Performance measures: Gait speed, TUG (timed

up and og test), grip strength

Page 27: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Walter et al, JAMA, 2001

Page 28: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Stanaway, BMJ, 2011

Grim reaper´s maximum speed: 1.36 m/s

Page 29: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

COMORBIDITY

Page 30: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Barnett et al, Lancet 2012

Chronic disorders by age-group

Page 31: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Comorbidity scales

• Charlson´s comorbidity index

• Weighted comorbidity index

• Predicted survival in cancer patients

• 19 selected conditions

Page 32: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital
Page 33: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

CIRS – cumulative illness rating scale

• Developed in 1968

• Revised in 1992

• Revised scoring manual in 2008

• Scores 14 organ systems – disease severity

possible to score

Page 34: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Optimization of comorbidities

• Call your geriatrician

• Or internal medicine specialist

• Core activity in the acute geriatric ward

• Competing risks

Page 35: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Polypharmacy

• Definitions vary

– More than 5 drugs in daily use

– The use of inappropriate medications

• Interactions

• Adverse events

• Polypharmacy is a risk factor for

undertreatment

Page 36: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Polypharmacy

• Goal: Dynamic approach

• What about drugs with a preventive effect?

• Discontinuation trials

Page 37: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital
Page 38: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Patients and methods• Multicenter, parallel-group, unblinded, pragmatic

clinical trial

• Estimated life expectancy 1 month - 1 year

• Statin therapy for 3 months or more for primary or sec. prevention of cardiovascular disease

• Recent deterioration in functional status

• No recent active cardiovascular disease

• Participants were randomized to either discontinue or continue statin therapy and were monitored monthly for up to 1 year

Page 39: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Conclusions

• Stopping statin medication therapy is

- safe

- may be associated with benefits including

improved quality of life

- use of fewer non-statin medications

Page 40: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Cognitive function

• Mild cognitive impairment

• Dementia

• Screening instruments, MMSE, MOCA, clock-

drawing test

Page 41: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Why important?

• Consent

• Prognosis

• Treatment planning

• Baseline - chemobrain

Page 42: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital
Page 43: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Patients and methods

• 1622 patients >70 years

• Assesses for cognitive impairment, dementia

excluded

• Follow-up 6 years

• Cognitive impairment: 60% increased

mortality (HR 1.62, CI 1.13-2.33)

Page 44: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Conclusions

• Cognitive impairment in the absence of

manifest dementia is associated with

increased mortality at 6 years and after

controlling for major risk factors

• The administration of cognitive tests among

older adults may provide relevant information

for patient care and treatment decisions

Page 45: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

NUTRITIONAL STATUS

Page 46: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Malnutrition

• Differs between countries – in Norway

malnutrition is the dominant problem

• Home dwelling: 6%, hospitals 40%, nursing

homes 14%

• Tool: mini nutritional assessment (MNA)

• Interventions possible – how?

Page 47: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

EMOTIONAL STATUS

Page 48: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Emotional function

• Depression and anxiety

• Common among older people

• Common among cancer patients

• Risk factors are pain and physical distress

• Fear of impeding mortality

• Protective: Attachment security, self-esteem, sense of meaning and purpose

• Treatment options?

Page 49: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Study (depression)1

• Older cancer patients (>70) receiving

chemotherapy (n=344)

• 45% depressed

• Risk factor: malnutrition at baseline

1Duc et al. Psychooncology, 2016

Page 50: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

SOCIAL SUPPORT

Page 51: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Social support

• Fundamental for treatment planning

• Population level – sociodemographic factors

strong predictors for receiving treatment

Page 52: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

GA COMPLETED – WHAT NOW?

Page 53: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Decrease in capacity - heterogeneity

Muravchik, Anesthesia 5th ed, 2000

Page 54: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

FRAILTY

“ An older patient who is at heightened vulnerability to adverse health status change because of a multisystem reduction in reserve

capacity”

The holy grail of geriatric medicine

Page 55: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Frailty

• Summarizes health status

• Frail patients have increased vulnerability to stressors

• No unified method for identifying frailty in an individual patient

• Accumulation of deficits based on geriatric assessment1

• Phenotypic model2 – functional assessment, does not include comorbidities or cognitive function

1Rockwood et al J Gerontol 20072Fried et al J Gerontol 2001

Page 56: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Frailty and chronological age1

• Frailty is closely associated with high age

• Frailty is associated with comorbidity

• Unique concept

• More precise quantification of individual

vulnerability than chronological age

alone1Hubbard et al. Biogerontology, 2010

Page 57: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Study: Older patients (70+) with

colorectal cancer

• Geriatric assessment pre-surgery

• Classified patients as fit, intermediate or frail

Kristjansson et al, CROH, 2010

Page 58: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Geriatric Assessment

178 patients

Mean 80 years

FIT

21

INTERMEDIATE

81FRAIL

76

Study cohort

Page 59: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

RESULTS

• Frail patients had more severe complications

than non-frail patients

• Age was not a predictor of complications

• Frail patients had poorer 5-year survival than

non-frail patients

• Age was not a predictor of survival

Kristjansson et al, CROH, 2010

Ommundsen et al, The Oncologist, 2014

Page 60: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

5-year survival by frailty status

Page 61: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

PSYCHOLOGICAL WELL-BEING AND AGE

1Stone et al. PNAS, 2010

Page 62: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

SUMMARY

• We live longer

• The heterogeneity increases with increasing

age

• We need to assess frailty rather than looking

at chronological age alone when deciding

interventions

• Geriatric assessment provides a practical

approach to older patients

• Functional status is underestimated

Page 63: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

THANK YOU FOR YOUR ATTENTION

Page 64: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Results

Page 65: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital
Page 66: Geriatric Assessment and Interventions - Geriatric oncology · Geriatric Assessment and Interventions Siri Rostoft, MD, PhD Department of Geriatric Medicine Oslo University Hospital

Conclusion

• Health-related quality of life may be improved

in older patients after elective surgery for

colorectal cancer, both at three months

postoperatively and after 1.5-2.5 years, even

in patients classified as frail preoperatively